William Ackman and his investment firm Pershing Square Capital Management have acquired a small stake in Procter & Gamble Co. and will likely push for changes to raise the struggling firm’s share price and bottom line, according to analysts.
Activist Investor May Urge P&G To Lose Non-Core Brands, McDonald
Changes may be ahead for Procter & Gamble following William Ackman and Pershing Square Capital Management’s investment in the Cincinnati-based consumer-goods giant. Analysts suggest the activist investor may push to replace CEO Bob McDonald and divest non-core brands.
More from Leadership
• By
The departure data emerged along with a Health and Human Services Department memo describing conceptual plans to consolidate and restructure offices at the FDA and other agencies.
• By
A round-up of the latest industry moves in Europe: Pharma Deutschland elects board of new Brussels operation; MHRA's new CEO gets to work; Futura names non-executive director.
• By
The General Services Administration’s updated list of “assets identified for accelerated disposition” does not include any buildings at the agency’s headquarters in White Oak, MD after its original list of “non-core” government properties for disposal had more than half the buildings on campus.
• By
Round up of the latest appointments: PAGB names vice presidents; Activ'Inside gets first US head; EMA elects management board chair.
More from HBW Insight
• By
Agreement with Seoul-based health and wellness player TopHealth will see the roll out of ProBiotix' cholesterol-lowering probiotics in South Korea.
• By
The Visby Medical Women’s Sexual Health Test is the first over-the-counter test cleared by the US Food and Drug Administration to detect chlamydia, gonorrhea and trichomoniasis. It delivers results in about 30 minutes.
• By
“I’m not sure exactly if they understood how broad this actually is and what that might potentially lead to or what the follow-up would be if somebody now decides to sell a 10-milligram version of ivermectin for human use,” says food and drug regulation attorney Frederick Stearns.